Fig. 2From: Perspectives of pharmaceutical stakeholders on determinants of medicines accessibility at the primary care levelSummarization of Strengths, Weaknesses, Opportunities and Challenges (SWOC) analysis done utilizing the available qualitative dataBack to article page